High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.


BACKGROUND The aim of this study was to determine whether several pleural fluid (PF) tumor markers, either alone or in combination, could be used to predict survival time of patients with malignant pleural effusion secondary to adenocarcinoma or squamous cell carcinoma. METHODS A total of 224 patients with confirmed metastatic pleural malignancies due to… (More)
DOI: 10.1016/j.ejim.2008.11.009